Breast Implant Exchange Surgery

A Mastopexy, also known as breast uplift surgery is designed to lift the breast by removing and pulling the skin taught around the breast tissue. In some cases, patients will require not only to remove (or replace) the original implant, but also condition and restore the natural bounce and shape of their breasts.

The only way to change the size and shape of the breast after breast augmentation surgery is by replacing the implant for a new size or shape. It is possible for patients to increase or decrease the size of their existing breast implant with our expert team at Cosmetic Surgery Partners.

At our cosmetic surgery clinic, we use the highest quality brands including Nagor implants, which are not only certified as safe by FDA and CE standards, they also hold a lifetime guarantee against rupturing. Our breast cosmetic surgeons will be able to advise you for the best type of shape and size during your initial consultation. Depending on your unique situation we may suggest another brand or profile, your surgeon will be able to advise you on which breast implant is appropriate to achieve the best result.

Yes, many patients we see come to us a result of being fitted with faulty PIP breast implants. Our surgeons are not only able to replace the PIP for a reputable and safe brand, but are also able to address poor choice of size, shape and even positioning of the original breast implant.

Our breast cosmetic surgeons are experts in producing natural looking results and will always aim to replace the patient’s breast implants through existing incisions. In some cases, our surgeons are able to reduce and minimise any overt scarring as a result of previous breast operations.

Every patient heals differently, however, on average we find that most patients are fully healed and ready to resume all daily activities at around 4-6 weeks post-breast implant exchange cosmetic surgery.

There is growing concern about the topic of Breast Implant Associated - Anaplastic Large Cell Lymphoma (BIA-ALCL). This very rare condition is a lymphoma and not cancer of the breast tissue. The Medicines and Healthcare products Regulatory Agency (MHRA) advises that breast implants are still regarded as safe for use in augmentation and reconstruction operations. The MHRA does not recommend a change in practice with the current data available.

The current recommendation from The British Association of Aesthetic Plastic Surgeons (BAAPS), FDA and the Gov.uk website can be found via the links below:

BIA-ALCL and BIA-SCC: 

https://www.gov.uk/guidance/breast-implants-and-anaplastic-large-cell-lymphoma-alcl 

https://baaps.org.uk/media/press_releases/1878/joint_statement_on_breast_implant_associated_squamous_cell_carcinoma_and_other_breast_implant_associated_lymphomas 

https://baaps.org.uk/_userfiles/pages/files/baaps_updated_statement_on_bii_october_2022.pdf 

https://www.fda.gov/medical-devices/safety-communications/update-reports-squamous-cell-carcinoma-scc-capsule-around-breast-implants-fda-safety-communication 

Should you have any further question please do not hesitate to contact our clinic who will be happy to answer your questions further, call 020 7486 6778.

There is growing concern about the topic of Breast Implant Associated - Anaplastic Large Cell Lymphoma (BIA-ALCL). This very rare condition is a lymphoma and not cancer of the breast tissue. The Medicines and Healthcare products Regulatory Agency (MHRA) advises that breast implants are still regarded as safe for use in augmentation and reconstruction operations. The MHRA does not recommend a change in practice with the current data available.

The current recommendation from The British Association of Aesthetic Plastic Surgeons (BAAPS), FDA and the Gov.uk website can be found via the links below:

BIA-ALCL and BIA-SCC: 

https://www.gov.uk/guidance/breast-implants-and-anaplastic-large-cell-lymphoma-alcl 

https://baaps.org.uk/media/press_releases/1878/joint_statement_on_breast_implant_associated_squamous_cell_carcinoma_and_other_breast_implant_associated_lymphomas 

https://baaps.org.uk/_userfiles/pages/files/baaps_updated_statement_on_bii_october_2022.pdf 

https://www.fda.gov/medical-devices/safety-communications/update-reports-squamous-cell-carcinoma-scc-capsule-around-breast-implants-fda-safety-communication 

Should you have any further question please do not hesitate to contact our clinic who will be happy to answer your questions further, call 020 7486 6778.